Resection of primary tumor in stage 4S neuroblastoma: a second study by the Italian Neuroblastoma Group
- PMID: 33123764
- DOI: 10.1007/s00383-020-04766-1
Resection of primary tumor in stage 4S neuroblastoma: a second study by the Italian Neuroblastoma Group
Abstract
Purpose: To clarify the role of primary tumor resection in stage 4S neuroblastoma.
Methods: We investigated a cohort of 172 infants diagnosed with stage 4S neuroblastoma between 1994 and 2013. Of 160 evaluable patients, 62 underwent upfront resection of the primary tumor and 98 did not.
Results: Five-year progression-free and overall survival were significantly better in those who had undergone upfront surgery (83.6% vs 64.2% and 96.8% vs 85.7%, respectively). One post-operative death and four non-fatal complications occurred in the resection group. Three patients who had not undergone resection died of chemotherapy-related toxicity. Thirteen patients underwent late surgery to remove a residual tumor, without complications: all but one alive. Outcomes were better in patients diagnosed from 2000 onwards.
Conclusion: Infants diagnosed with stage 4S neuroblastoma who underwent upfront tumor resection had a better outcome. However, this result cannot be definitely attributed to surgery, since these patients were selected on the basis of their favorable presenting features. Although the question of whether to operate or not at disease onset is still unsolved, this study confirms the importance of obtaining enough adequate tumor tissue to enable histological and biological studies to properly address treatment, to achieve the best possible outcome.
Keywords: Neuroblastoma; Primary tumor resection; Stage 4S; Surgery.
References
-
- D’Angio GJ, Evans AE, Koop C (1971) Special pattern of widespread neuroblastoma with a favorable prognosis. Lancet 1:1046–1049. https://doi.org/10.1016/s0140-6736(71)91606-0 - DOI - PubMed
-
- Brodeur GM, Pritchard J, Berthold F et al (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466–1477. https://doi.org/10.1200/JCO.1993.11.8.1466 - DOI - PubMed
-
- Brodeur GM (2018) Spontaneous regression of neuroblastoma. Cell Tissue Res. 372:277–286. https://doi.org/10.1007/s00441-017-2761-2 - DOI - PubMed - PMC
-
- Evans AE, Chatten J, D’Angio GJ, Gerson JM, Robinson J, Schnaufer L (1980) A review of 17 IV-S neuroblastoma patients at the Children’s Hospital of Philadelphia. Cancer 45:833–839. https://doi.org/10.1002/1097-0142(19800301)45:5%3c833::aid-cncr282045050... - DOI - PubMed
-
- Stokes SH, Thomas PR, Perez CA, Vietti TJ (1984) Stage IV-S neuroblastoma: results with definitive therapy. Cancer 53:2083–2086. https://doi.org/10.1002/1097-0142(19840515)53:10%3c2083::aid-cncr2820531... - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources